GGrantIndex
Sort

78,016 grants matching breast cancer

Biochemical Markers in the Nurses? Health Study Cohort

$1,024,262
Susan E. Hankinson · University Of Massachusetts Amherst · U01 · FY2013 · CA

Redes En Accion::The National Hispanic/Latino Cancer Network Research Network

$1,024,234
Amelie G Ramirez · University Of Texas Hlth Science Center · U54 · FY2012 · CA

Upstate Carolina Community Clinical Oncology Program

$1,023,952
Spartanburg Regional Medical Center · U10 · FY2001 · CA

Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke

$1,023,777
Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2010 · CA

Late Effects of Treatment in Wilms Tumor Survivors and Offspring

$1,023,737
Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA

MammoCAT Advanced Full Field Digital Mammography System

$1,023,397
Shabbir Bakir Bambot · Fischer Imaging, Inc. · R44 · FY2022 · CA

Breast CT scanner for earlier cancer detection

$1,023,177
John M Boone · University Of California At Davis · R01 · FY2012 · EB

HELPING THE MOTHER WITH BREAST CANCER SUPPORT HER CHILD

$1,023,118
University Of Washington · R01 · FY2001 · CA

STRATEGIES TO COUNTERACT RESISTANCE MECHANISMS IN CAR+ T-CELL-BASED IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER

$1,023,084
The General Hospital Corporation · · FY2016 · Department of the Army

Nuclear Structure and Gene Expression

$1,023,075
Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2013 · CA

XoLacta: An Adjuvant Therapy for treatment of Radiation Side effects during HER2-Positive Breast Cancer Treatment

$1,022,907
Spencer Reid Marsh · Tiny Cargo Company, The · R44 · FY2025 · CA

UIC CENTERS FOR POPULATION HEALTH AND HEALTH DISPARITIES

$1,022,849
Elizabeth Ann Calhoun · University Of Illinois At Chicago · P50 · FY2011 · CA

Molecular Analysis Of Cell Cycle Control During Carcinogenesis

$1,022,497
Richard Paules · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES

Clinical Trials Units for NIAID Networks (UM1)

$1,022,484
Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2015 · AI

Environmental Exposure and DNA Damage

$1,022,337
Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES

Stalled replication fork repair in cancer predisposition and cancertherapy

$1,022,022
Ralph Scully · Beth Israel Deaconess Medical Center · R35 · FY2022 · CA

Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial

$1,021,979
Kathryn H. Schmitz · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · CA

Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1

$1,021,968
Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Cellular Interactions with Thrombospondin

$1,021,874
David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA

Fox Chase Clinical Epidemiology and Validation Center

$1,021,244
Paul F. Engstrom · Fox Chase Cancer Center · U01 · FY2008 · CA

Functionally Validated Lentiviral siRNA libraries

$1,021,240
Alex Chenchik · Cellecta, Inc. · R44 · FY2011 · RR

Comparative Biomedical Scientist Training Program

$1,021,229
Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2014 · CA

VANGUARD CENTER FOR WOMEN'S HEALTH INITIATIVE

$1,020,787
Emory University · N01 · FY2000 · WH

Cellular Interactions with Thrombospondin

$1,020,647
David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA

Interactive MR Image Guided Intervention (iMR-IGI) for Breast Applications

$1,020,481
Raymond D Harter · Marvel Medtech, Llc · R44 · FY2015 · CA